已完成 NCT04185922

Hemopatch 用于预防机械人前列腺切除术及盆腔淋巴结清扫术后淋巴渗漏

前列腺癌不适用

机械人前列腺切除术(RARP)是治疗局部前列腺癌的手术。若估计隐匿性淋巴结转移风险超过5%,亦会进行双侧盆腔淋巴结清扫术(BPLND)。BPLND 一般而言是耐受性良好的手术。淋巴渗漏是淋巴结清扫术(BPLND)后可能的并发症之一。淋巴囊肿是手术后淋巴液的积聚。

适应症:Prostate Cancer

入组条件

纳入标准

  • Age 18 years and above
  • Able to give informed consent
  • Suitable for minimally-invasive surgery

排除标准

  • Known allergy or hypersensitivity to any component of Hemopatch®
  • Known hypersensitivity to bovine proteins or brilliant blue
  • Patients with prior pelvic radiotherapy
  • Patients with non-correctable coagulopathy
  • Patients who are on anticoagulants
  • Contraindication to general anaesthesia
  • Previous transurethral resection of the prostate or prostatic surgery
  • Untreated active infection

入组条件维持 ClinicalTrials.gov 原始英文登记资料,实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源:ClinicalTrials.gov,每两周自动更新,最后同步:2026年11月5日。